A groundbreaking care model is reshaping how we treat inflammatory bowel disease (IBD). Through a collaborative effort between UPMC, Cleveland…
Browsing: Clinical Updates
Fecal microbiota transplants (FMT), once heralded as a miracle fix for gut-related diseases, may come with unintended consequences, according to…
A new peer-reviewed study published in Radiology shows that CT colonography (CTC) not only reduces colorectal cancer incidence more effectively…
In a field where precision and endurance go hand in hand, Dr. Amandeep Shergill—professor of clinical medicine at UCSF—is quietly…
Freenome just published pivotal trial results for its blood-based colorectal cancer (CRC) screening test in JAMA. With 79.2% sensitivity for…
Here’s a quick glimpse of highlights from the June 2025 issue of The American Journal of Gastroenterology:
At the 2025 National Lipid Association conference, a compelling shift emerged: GLP-1 receptor agonists like semaglutide (Ozempic) may protect the…
Colorectal cancer (CRC) remains the second leading cause of cancer death in the U.S.—even as incidence and mortality have declined.…
For patients with IBD, monitoring the disease often means enduring repeat colonoscopies—uncomfortable, invasive, and time-consuming. But Pfizer is helping change…
What if a workout routine could rival traditional cancer treatments? At the ASCO Annual Meeting, a groundbreaking trial revealed that…